Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

CD74-NRG1 fusion

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

CD74-NRG1 fusion	Lung Adenocarcinoma	CD74-NRG1 fusion	Lung Adenocarcinoma	afatinib Sensitive: C3 – Early Trials afatinib Sensitive : C3	afatinib Sensitive: C3 – Early Trials afatinib Sensitive : C3
CD74-NRG1 fusion	Non Small Cell Lung Cancer	CD74-NRG1 fusion	Non Small Cell Lung Cancer	afatinib Sensitive: C4 – Case Studies afatinib Sensitive : C4	afatinib Sensitive: C4 – Case Studies afatinib Sensitive : C4
CD74-NRG1 fusion	Non Small Cell Lung Cancer	CD74-NRG1 fusion	Non Small Cell Lung Cancer	zenocutuzumab-zbco Sensitive: C4 – Case Studies zenocutuzumab-zbco Sensitive : C4	zenocutuzumab-zbco Sensitive: C4 – Case Studies zenocutuzumab-zbco Sensitive : C4
CD74-NRG1 fusion	Lung Cancer	CD74-NRG1 fusion	Lung Cancer	MM-121 Sensitive: D – Preclinical MM-121 Sensitive : D	MM-121 Sensitive: D – Preclinical MM-121 Sensitive : D